Various pharmaceutical disperse systems

Pharmaceutical Suspensions: From Formulation Development to Manufacturing

Volumn , Issue , 2010, Pages 1-37

  Manoharan, Chandrasekar ^a   Basarkar, Ashwin ^a   Singh, Jagdish ^a  

^a NORTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84920183035     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4419-1087-5_1     Document Type: Chapter

References (126)

1. Angelico, R., Palazzo, G., Colafemmina, G., Cirkel, P.A., Giustini, M., and Ceglie, A. 1998. Water diffusion and head group mobility in polymer-like reverse micelles: evidence of a sphere-torod- To-sphere transition. J Phys Chem B. 102:2883-2889.
2. Ansel, C.H., Popovich, N.G., and Allen, L.V. Jr. 1995. Pharmaceutical Dosage Forms and Drug Delivery Systems. Philadelphia: Williams and Wilkins.
3. Attwood, D. 1994. Microemulsion. In: Kreuter, J. (ed.) Colloidal Drug Delivery System. New York: Marcel Dekker, pp. 31-65.
4. Becher, P. 1977. Emulsions: Theory and Practice, New York: Krieger.
5. Bilati, U., Allemann, E., and Doelker, E. 2005. Strategic approaches for overcoming peptide and protein instability within biodegradable nano- And microparticles. Eur J Pharm Biopharm. 59:375-388.
6. Bittner, B., Morlock, M., Koll, H., Winter, G., and Kissel, T. 1998. Recombinant human erythropoietin (rhEPO) loaded poly(lactide-co-glycolide) microspheres: influence of the encapsulation technique and polymer purity on microsphere characteristics. Eur J Pharm Biopharm. 45:295-305.
7. Bjerregaard, S., Wulf-Andersen, L., Stephens, R.W., Lund, L.R., Vermehren, C., Soderberg, I., and Frokjaer, S. 2001a. Sustained elevated plasma aprotinin concentration in mice following intraperitoneal injections of w/o emulsions incorporating aprotinin. J Control Release. 71:87-98.
8. Bjerregaard, S., Pedersen, H., Vedstesen, H., Vermehren, C., Soderberg, I., and Frokjaer, S. 2001b. Parenteral water/oil emulsions containing hydrophilic compounds with enhanced in vivo retention: formulation, rheological characterisation and study of in vivo fate using whole body gamma-scintigraphy. Int J Pharm. 215:13-27.
9. Bjerregaard, S., Söderberg, I., Vermehren, C., and Frokjaer, S. 1999a. The effect of controlled osmotic stress on release and swelling properties of a water-in-oil emulsion. Int J Pharm. 183:17-20.
10. Bjerregaard, S., Söderberg, I., Vermehren, C., and Frokjaer, S. 1999b. Formulation and evaluation of release and swelling mechanism of a water-in-oil emulsion using factorial design. Int J Pharm. 193:1-11.
11. Burgess, J.D. and Hickey, J.A. 2005. Microspheres: design and manufacturing. In: Burgess, J.D. (ed.) Injectable Disperse Systems. New York: Taylor & Francis Group, pp. 305-353.
12. Capan, Y., Woo, B.H., Gebrekidan, S., Ahmed, S., and De Luca, P.P. 1999. Preparation and characterization of poly (d, l-lactide-co-glycolide) microspheres for controlled release of poly(llysine) complexed plasmid DNA. Pharm Res. 16:509-513.
13. Capek, I. 2004. Degradation of kinetically-stable o/w emulsions. Adv Colloid Interface Sci. 107:125-155.
14. Carrascosa, C., Torres-Aleman, I., Lopez-Lopez, C., Carro, E., Espejo, L., Torrado, S., and Torrado, J.J. 2004. Microspheres containing insulin-like growth factor I for treatment of chronic neurodegeneration. Biomaterials. 25:707-714.
15. Carrigan, P.J. and Bates, T.R. 1973. Biopharmaceutics of drugs administered in lipid-containing dosage forms. I. GI absorption of griseofulvin from an oil-in-water emulsion in the rat. J Pharm Sci. 62:1476-1479.
16. Cattel, L., Ceruti, M., and Dosio, F. 2003. From conventional to stealth liposomes: A new frontier in cancer chemotherapy. Tumori. 89:237-249.
17. Charcosset, C., Limayem, I., and Fessi, H. 2004. The membrane emulsification process - A review. J Chem Technol Biotechnol. 79:209-218.
18. Chattopadhyay, P. and Gupta, R.B. 2001. Production of griseofulvin nanoparticles using supercritical CO(2) antisolvent with enhanced mass transfer. Int J Pharm. 228:19-31.
19. Chen, Y., Liu, J., Yang, X., Zhao, X., and Xu, H. 2005. Oleanolic acid nanosuspensions: preparation, in-vitro characterization and enhanced hepatoprotective effect. J Pharm Pharmacol. 57:259-264.
20. Clausse, D., Gomez, F., Pezron, I., Komunjer, L., and Dalmazzone, C. 2005. Morphology characterization of emulsions by differential scanning calorimetry. Adv Colloid Interface Sci. 117:59-74.
21. Cohen, H., Levy, R.J., Gao, J., Fishbein, I., Kousaev, V., Sosnowski, S., Slomkowski, S., and Golomb, G. 2000. Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles. Gene Ther. 7:1896-1905.
22. Danielson, I. and Lindman, B. 1981. The definition of microemulsion. Colloids Surf. 3:391-392.
23. Dass, C.R. and Burton, M.A. 2003. Modified microplex vector enhances transfection of cells in culture while maintaining tumour-selective gene delivery in-vivo. J Pharm Pharmacol. 55:19-25.
24. Davis, S.S., Hadgraft, J., and Palin, J.K. 1985. Medical and pharmaceutical applications of emulsions. In: Becher, P. (ed.) Encyclopedia of Emulsion Technology. New York: Marcel Dekker, pp. 159-238.
25. Davis, S.S. 1997. Biomedical applications of nanotechnology - implications for drug targeting and gene therapy. Trends Biotechnol. 15:217-224.
26. De Smedt, S.C., Demeester, J., and Hennink, W.E. 2000. Cationic polymer based gene delivery systems. Pharm Res. 17:113-126.
27. Deng, Z., Zhao, R., Dong, L.-C., and Wong, G. 2005. Characterization of nanoparticles for drug delivery applications. Microsc Microanal. 11(Suppl 2):1934-1935.
28. Diamond, L. 1970. A comparison of the gastrointestinal absorption profiles of theophylline from various vehicles. Arch Int Pharmacodyn Ther. 185:246-253.
29. Dobson, J. 2006. Gene therapy progress and prospects: magnetic nanoparticle-based gene delivery. Gene Ther. 13:283-287.
30. Elvassore, N., Bertucco, A., and Caliceti, P. 2001. Production of insulin-loaded poly(ethylene glycol)/poly(l-lactide) (PEG/PLA) nanoparticles by gas antisolvent techniques. J Pharm Sci. 90:1628-1636.
31. Felgner, P.L., Gadek, T.R., Holm, M., Roman, R., Chan, H.W., Wenz, M., Northrop, J.P., Ringold, G.M., and Danielsen, M. 1987. Lipofection: A highly efficient, lipid-mediated DNAtransfection procedure. Proc Natl Acad Sci U S A. 84:7413-7417.
32. Forster, T., Rybinski, W., and Wadle, A. 1995. Influence of microemulsion phases on the preparation of fine disperse emulsions. Adv Colloid Interface. 58:119-149.
33. Furtado, S., Abramson, D., Simhkay, L., Wobbekind, D., and Mathiowitz, E. 2006. Subcutaneous delivery of insulin loaded poly(fumaric-co-sebacic anhydride) microspheres to type 1 diabetic rats. Eur J Pharm Biopharm. 63:229-236.
34. Gagnon, M. and Dawson, A.M. 1968. The effect of bile on vitamin A absorption in the rat. Proc Soc Exp Biol Med. 127:99-102.
35. Garcia-Celma, M.J. 1997. Solubilization of drugs in microemulsions. In: Solans, C. and Kunieda H. (eds.) Industrial Applications of Microemulsions. New York: Marcel Dekker, pp. 123-145.
36. Gaucher, G., Dufresne, M.H., Sant, V.P., Kang, N., Maysinger, D., and Leroux, J.C. 2005. Block copolymer micelles: preparation, characterization and application in drug delivery. J Control Release. 109:169-188.
37. Ghaderi, R., Sturesson, C., and Carlfors, J. 1996. Effect of preparative parameters on the characteristics of poly (d, l-lactide-co-glycolide) microspheres made by the double emulsion method. Int J Pharm. 141:205-216.
38. Gietz, U., Arvinte, T., Haner, M., Aebi, U., and Merkle, H.P. 2000. Formulation of sustained release aqueous Zn-hirudin suspensions. Eur J Pharm Sci. 11:33-41.
39. Gietz, U., Arvinte, T., Mader, E., Oroszlan, P., and Merkle, H.P. 1998. Sustained release of injectable zinc-recombinant hirudin suspensions: development and validation of in vitro release model. Eur J Pharm Biopharm. 45:259-264.
40. Gillberg, G., Lehtinen, H., and Friberg, S. 1970. NMR and IR investigation of the conditions determining the stability of microemulsions. J Colloid Interface Sci. 33:40-53.
41. Giovagnoli, S., Blasi, P., Schoubben, A., Rossi, C., and Ricci, M. 2007. Preparation of large porous biodegradable microspheres by using a simple double-emulsion method for capreomycin sulfate pulmonary delivery. Int J Pharm. 333:103-111.
42. Griffin, W.C. 1949. Classification of surface-active agents by HLB. J Soc Cosmet Chem. 1:311.
43. Gupta, A.K. and Gupta, M. 2005. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials. 26:3995-4021.
44. Higashi, S., Shimizu, M., Nakashima, T., Iwata, K., Uchiyama, F., Tateno, S., Tamura, S., and Setoguchi, T. 1995. Arterial-injection chemotherapy for hepatocellular carcinoma using monodispersed poppy-seed oil microdroplets containing fine aqueous vesicles of epirubicin. Initial medical application of a membrane-emulsification technique. Cancer. 75:1245-1254.
45. Hoar, T.P. and Schulman, J.H. 1943. Transparent water-in-oil dispersions: The oleopathic hydromicelle. Nature. 152:102-105.
46. Jacobs, C. and Muller, R.H. 2002. Production and characterization of a budesonide nanosuspension for pulmonary administration. Pharm Res. 19:189-194.
47. Jacobs, C., Kayser, O., and Muller, R.H. 2000. Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide. Int J Pharm. 196:161-164.
48. Jain, R.A., Wei, L., and Swanson, J. 2000. Solid dose form of nanoparticulate naproxen. US Patent 6165506.
49. Jain, S.K., Jain, R.K., Chourasia, M.K., Jain, A.K., Chalasani, K.B., Soni, V., and Jain, A. 2005. Design and development of multivesicular liposomal depot delivery system for controlled systemic delivery of acyclovir sodium. AAPS Pharm Sci Tech. 6:E35-E41.
50. Jia, L., Wong, H., Cerna, C., and Weitman, S.D. 2002. Effect of nanonization on absorption of 301029: ex vivo and in vivo pharmacokinetic correlations determined by liquid chromatography/mass spectrometry. Pharm Res. 19:1091-1096.
51. Jiang, W. and Schwendeman, S.P. 2001. Stabilization and controlled release of bovine serum albumin encapsulated in poly(d, l-lactide) and poly(ethylene glycol) microsphere blends. Pharm Res. 18:878-885.
52. Johnson, O.L., Jaworowicz, W., Cleland, J.L., Bailey, L., Charnis, M., Duenas, E., Wu, C., Shepard, D., Magil, S., Last, T., Jones, A.J., and Putney, S.D. 1997. The stabilization and encapsulation of human growth hormone into biodegradable microspheres. Pharm Res. 14:730-735.
53. Jones, M. and Leroux, J. 1999. Polymeric micelles - A new generation of colloidal drug carriers. Eur J Pharm Biopharm. 48:101-111.
54. Kabanov, A., Zhu, J., and Alakhov, V. 2005. Pluronic block copolymers for gene delivery. Adv Genet. 53:231-261.
55. Kabanov, A.V., Batrakova, E.V., Melik-Nubarov, N.S., Fedoseev, N.A., Dorodnich, T.Y., Alakhov, V.Y., Chekhonin, P., Nazarova, I.R., and Kabanov, V.A. 1992. A new class of drug carriers; micells poly(oxyethylene)-poly(oxypropylene) block copolymers as microcontainers for drug targeting from blood to brain. J Control. Release. 22:141-158.
56. Kang, F. and Singh, J. 2005. Preparation, in vitro release, in vivo absorption and biocompatibility studies of insulin-loaded microspheres in rabbits. AAPS Pharm Sci Tech. 6:E487-E494.
57. Khan, A.Y., Talegaonkar, S., Iqbal, Z., Ahmed, F.J., and Khar, R.K. 2006. Multiple emulsions: An overview. Curr Drug Deliv. 3:429-443.
58. Kim, S.K., Lee, E.H., Vaishali, B., Lee, S., Lee, Y.K., Kim, C.Y., Moon, H.T., and Byun, Y. 2005. Tricaprylin microemulsion for oral delivery of low molecular weight heparin conjugates. J Control Release. 105:32-42.
59. Klang, S.H., Siganos, C.S., and Benita, S. 1999. Evaluation of a positively charged submicron emulsion of piroxicam in the rabbit corneum healing process following alkali burn. J Control Release. 57:19-27.
60. Klang, S., Abdulrazik, M., and Benita, S. 2000. Influence of emulsion droplet surface charges on indomethacin ocular tissue distribution. Pharm Dev Technol. 5:521-532.
61. Klibanov, A.M., Maruyama, M., Torchilin, V.P., and Huang, L. 1990. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett. 268:235-237.
62. Kocbek, P.S., Baumgartner, S., and Kristl, J. 2006. Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs. Int J Pharm. 312:179-186.
63. Kreilgaard, M. 2002. Influence of microemulsions on cutaneous drug delivery. Adv Drug Deliv Rev. 54(Suppl 1):S77-S98.
64. Kreuter, J., Alyautdin, R.N., Kharkevich, D.A., and Ivanov, A.A. 1995. Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles). Brain Res. 674:171-174.
65. Kumar, M. 2000. Nano and microparticles as controlled drug delivery devices. J Pharm Pharm Sci. 3:234-258.
66. Kwon, G.S., Naito, M., Yokoyama, M., Okano, T., Sakurai, Y., and Kataoka, K. 1997. Block copolymer micelles for drug delivery: loading and release of doxorubicin. J Control Release. 48:195-201.
67. Lamprecht, A., Yamamoto, H., Takeuchi, H., and Kawashima, Y. 2004. pH-sensitive microsphere delivery increases oral bioavailability of calcitonin. J Control Release. 98:1-9.
68. Lasic, D.D. 1992. Mixed micelles in drug delivery. Nature. 355:279-280.
69. Lasic, D.D. 1998. Novel applications of liposomes. Trends Biotechnol. 16:307-321.
70. Lawrence, M.J., and Rees, G.D. 2000. Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev. 45:89-121.
71. Lemieux, P., Vinogradov, S.V., Gebhart, C.L., Guerin, N., Paradis, G., Nguyen, H.K., Ochietti, B., Suzdaltseva, Y.G., Bartakova, E.V., Bronich, T.K., St-Pierre, Y., Alakhov, V.Y., and Kabanov, A.V. 2000. Block and graft copolymers and NanoGel copolymer networks for DNA delivery into cell. J Drug Target. 8:91-105.
72. Lian, T. and Ho, R.J. 2001. Trends and developments in liposome drug delivery systems. J Pharm Sci. 90:667-680.
73. Lipinski, C. 2002. Poor aqueous solubility - An industry wide problem in drug delivery. Am Pharm Rev. 5:82-85.
74. Liversidge, G.G., and Conzentino, P. 1995. Drug particle reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats. Int J Pharm. 125:309-313.
75. Martin, A., Swarbrick, J., and Cammarata, A. (eds.) 1983. Coarse dispersions. In: Physical Pharmacy, 3rd edn. Philadelphia: Lea and Febiger, p. 544.
76. Martinez-Sancho, C., Herrero-Vanrell, R., and Negro, S. 2006. Vitamin A palmitate and aciclovir biodegradable microspheres for intraocular sustained release. Int J Pharm. 326:100-106.
77. Masuda, K., Horie, K., Suzuki, R., Yoshikawa, T., and Hirano, K. 2003. Oral-antigen delivery via a water-in-oil emulsion system modulates the balance of the Th1/Th2 type response in oral tolerance. Pharm Res. 20:130-134.
78. Masuoka, J., Hegenauer, J., Van Dyke, B.R., and Saltman, P. 1993. Intrinsic stoichiometric equilibrium constants for the binding of zinc(II) and copper(II) to the high affinity site of serum albumin. J Biol Chem. 268:21533-21537.
79. Merisko-Liversidge, E., Liversidge, G.G., and Cooper, E.R. 2003. Nanosizing: A formulation approach for poorly-water-soluble compounds. Eur J Pharm Sci. 18:113-120.
80. Mittal, K.L., and Lindman, B (eds.) 1991. Surfactants in solution (Vol. 3). New York: Plenum Press.
81. Mizushima, Y., Hoshi, K., Aihara, H., and Kurachi, M. 1983. Inhibition of bronchoconstriction by aerosol of a lipid emulsion containing prostaglandin E1. J Pharm Pharmacol. 35:397.
82. Morales, M.E., Gallardo, V., Calpena, A.C., Doménech, J., and Ruiz, M.A. 2004. Comparative study of morphine diffusion from sustained release polymeric suspensions. J Control Rel. 95:75-81.
83. Morishita, I., Morishita, M., Takayama, K., Machida, Y., and Nagai, T. 1993. Enteral insulin delivery by microspheres in 3 different formulations using Eudragit L100 and S100. Int J Pharm. 91:29-37.
84. Moschwitzer, J., Achleitner, G., Pomper, H., and Muller, R.H. 2004. Development of an intravenously injectable chemically stable aqueous omeprazole formulation using nanosuspension technology. Eur J Pharm Biopharm. 58:615-619.
85. Moschwitzer, J. and Muller, R.H. 2006. New method for the effective production of ultrafine drug nanocrystals. J Nanosci Nanotechnol. 6: 3145-3153.
86. Mu, L., Elbayoumi, T.A., and Torchilin, V.P. 2005. Mixed micelles made of poly(ethylene glycol)- phosphatidylethanolamine conjugate and d-alpha-tocopheryl polyethylene glycol 1000 succinate as pharmaceutical nanocarriers for camptothecin. Int J Pharm. 306:142-149.
87. Murakami, H. and Nakashima, N. 2006. Soluble carbon nanotubes and their applications. J Nanosci Nanotechnol. 6:16-27.
88. Myers, D. 1992. Surfactant Science and Technology, 2nd ed. New York: VCH Publishers, Inc.
89. Nash, R.A. 1988. Pharmaceutical suspensions. In: Liebermann, H.A., Rieger, M.M., and Banker, G.S. (eds.) Pharmaceutical Dosage Forms: Disperse Systems (Vol. 1). New York and Basel: Mercer Dekker, Inc., pp. 151-198.
90. Nishiyama, N. and Kataoka, K. 2003. Polymeric micelle drug carrier systems: PEG-PAsp(Dox) and second generation of micellar drugs. Adv Exp Med Biol. 519:155-177.
91. Olivier, J.C. 2005. Drug transport to brain with targeted nanoparticles. Neuro Rx. 2:108-119.
92. Pandey, R. and Khuller, G.K. 2004. Chemotherapeutic potential of alginate-chitosan microspheres as anti-tubercular drug carriers. J Antimicrob Chemother. 53:635-640.
93. Papahadjopoulos, D., Allen, T.M., Gabizon, A., Mayhew, E., Matthay, K., Huang, S.K., Lee, K.D., Woodle, M.C., Lasic, D.D., Redemann, C., and Martin, F.J. 1991. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci U S A. 88:11460-11464.
94. Paul, B.K. and Moulik, S.P. 1997. Microemulsions: An overview. J Dispers Sci Technol. 18:301-67.
95. Pignatello, R., Bucolo, C., Ferrara, P., Maltese, A., Puleo, A., and Puglisi, G. 2002. Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen. Eur J Pharm Sci. 16:53-61.
96. Rabinow, B.E. 2004. Nanosuspensions in drug delivery. Nat Rev Drug Discov. 3:785-796.
97. Rabinow, B., Kipp, J., Papadopoulos, P., Wong, J., Glosson, J., Gass, J., Sun, C.S., Wielgos, T., White, R., Cook, C., Barker, K., and Wood, K. 2007. Itraconazole IV nanosuspension enhances efficacy through altered pharmacokinetics in the rat. Int J Pharm. 339:251-260.
98. Ravi Kumar, M., Hellermann, G., Lockey, R.F., and Mohapatra, S.S. 2004. Nanoparticle-mediated gene delivery: state of the art. Expert Opin Biol Ther. 4:1213-1224.
99. Rubinstein, A., Pathak, Y.V., Kleinstern, J., Reches, A., and Benita, S. 1991. In vitro release and intestinal absorption of physostigmine salicylate from submicron emulsions. J Pharm Sci. 80:643-647.
100. Sandhu, K.K., McIntosh, C.M., Simard, J.M., Smith, S.W., and Rotello, V.M. 2002. Gold nanoparticlemediated transfection of mammalian cells. Bioconjug Chem. 13:3-6.
101. Schulman, J.H., Stoeckenius, W., and Prince, L.M. 1959. Mechanism of formation and structure of microemulsions by electron microscopy. J Phys Chem. 63:1677-1680.
102. Shenoy, D.B., D'Souza, R.J., Tiwari, S.B., and Udupa, N. 2003. Potential applications of polymeric microsphere suspension as subcutaneous depot for insulin. Drug Dev Ind Pharm. 29:555-563.
103. Shenoy, D., Fu, W., Li, J., Crasto, C., Jones, G., Dimarzio, C., Sridhar, S., and Amiji, M. 2006. Surface functionalization of gold nanoparticles using hetero-bifunctional Poly (ethylene glycol) spacer for intracellular tracking and delivery. Int J Nanomedicine. 1:51-58.
104. Silva, C.M., Ribeiro, A.J., Figueiredo, I.V., Goncalves, A.R., and Veiga, F. 2006. Alginate microspheres prepared by internal gelation: development and effect on insulin stability. Int J Pharm. 311:1-10.
105. Steckel, H., Thies, J., and Muller, B.W. 1997. Micronizing of steroids for pulmonary delivery by supercritical carbon dioxide. Int J Pharm. 152:99-110.
106. Stella, V.J., Umprayn, K., and Waugh, W.N. 1988. Development of parenteral formulations of experimental cytotoxic agents. I. Rhizoxin (NSC-332598). Int J Pharm. 43:191-199.
107. Swainston Harrison, T., Plosker, G.L., and Keam, S.J. 2006. Extended-release intramuscular naltrexone. Drugs. 66:1741-1751.
108. Talsma, S.S., Babensee, J.E., Murthy, N., and Williams, I.R. 2006. Development and in vitro validation of a targeted delivery vehicle for DNA vaccines. J Control Release. 112:271-279.
109. Tarr, B.D., Sambandan, T.G., and Yalkowsky, S.H. 1987. A new parenteral emulsion for the administration of taxol. Pharm Res. 4:162-165.
110. Tenjarla, S. 1999. Microemulsions: An overview and pharmaceutical applications. Crit Rev Ther Drug Carrier Syst. 16:461-521.
111. Tewes, F., Boury, F., and Benoit, J.P. 2005. Biodegradable microspheres: Advances in production technology. In: Benita, S. (ed) Microencapsulation: Methods and Industrial Applications. New York: Taylor & Francis Group, pp. 1-53.
112. Torchilin, V.P. 2002. PEG-based micelles as carriers of contrast agents for different imaging modalities. Adv Drug Deliv Rev. 54:235-252.
113. Torchilin, V.P. 2006. Recent approaches to intracellular delivery of drugs and DNA and organelle targeting. Annu Rev Biomed Eng. 8:343-375.
114. Torchilin, V.P. 2007. Micellar nanocarriers: pharmaceutical perspectives. Pharm Res. 24:1-16.
115. Van Vlerken, L.E. and Amiji, M.M. 2006. Multi-functional polymeric nanoparticles for tumourtargeted drug delivery. Expert Opin Drug Deliv. 3:205-216.
116. Veronese, F.M., Marsilio, F., Caliceti, P., De Filippis, P., Giunchedi, P., and Lora, S. 1998. Polyorganophosphazene microspheres for drug release: polymer synthesis, microsphere preparation, in vitro and in vivo naproxen release. J Control Release. 52:227-237.
117. Vladisavljevic, G.T. and Williams, R.A. 2005. Recent developments in manufacturing emulsions and particulate products using membranes. Adv Colloid Interface Sci. 113:1-20.
118. Vogt, A., Combadiere, B., Hadam, S., Stieler, K.M., Lademann, J., Schaefer, H., Autran, B., Sterry, W., and Blume-Peytavi, U. 2006. 40 nm, but not 750 or 1, 500 nm, nanoparticles enter epidermal CD1a + cells after transcutaneous application on human skin. J Invest Dermatol. 126:1316-1322.
119. Walstra, P. 1983. Formation of emulsions. In: Becher, P. (ed) Encyclopedia of Emulsion Technology. New York: Marcel Dekker, pp. 57-127.
120. Wang, L.Y., Gu, Y.H., Su, Z.G., and Ma, G.H. 2006. Preparation and improvement of release behavior of chitosan microspheres containing insulin. Int J Pharm. 311:187-195.
121. Wang, S.H., Zhang, L.C., Lin, F., Sa, X.Y., Zuo, J.B., Shao, Q.X., Chen, G.S., and Zeng, S. 2005. Controlled release of levonorgestrel from biodegradable poly (d, l-lactide-co-glycolide) microspheres: in vitro and in vivo studies. Int J Pharm. 301:217-225.
122. Wei, G., Pettway, G.J., McCauley, L.K., and Ma, P.X. 2004. The release profiles and bioactivity of parathyroid hormone from poly(lactic-co-glycolic acid) microspheres. Biomaterials. 25:345-352.
123. Yamaguchi, M., Yasueda, S., Isowaki, A., Yamamoto, M., Kimura, M., Inada, K., and Ohtori, A. 2005. Formulation of an ophthalmic lipid emulsion containing an anti-inflammatory steroidal drug, difluprednate. Int J Pharm. 301:121-128.
124. Yasugi, K., Nagasaki, Y., Kato, M., and Kataoka, K. 1999. Preparation and characterization of polymer micelles from poly(ethylene glycol)-poly(d, l-lactide) block copolymers as potential drug carrier. J Control Release. 62:89-100.
125. Young, T.J., Mawson, S., Johnston, K.P., Henriksen, I.B., Pace, G.W., and Mishra, A.K. 2000. Rapid expansion from supercritical to aqueous solution to produce submicron suspensions of water-insoluble drugs. Biotechnol Prog. 16:402-407.
126. Yu, Z.J. and Neuman, R.D. 1995. Reversed micellar solution-to-bicontinuous microemulsion transition in sodium bis (2-ethylhexyl) phosphate/n-heptane/water system. Langmuir. 11:1081-1086.